Formoterol or tiotropium bromide do not influence isolated nocturnal hypoxemia in stable COPD
B. Sposato, M. Salvatore, M. M. Giovanna, R. Alberto, C. Elena, G. Aldo, M. Lia, P. Piero, F. Clemente (Grosseto, Roma, Italy)
Source: Annual Congress 2005 - COPD - treatment III
Session: COPD - treatment III
Session type: Thematic Poster Session
Number: 1959
Disease area: Sleep and breathing disorders
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Sposato, M. Salvatore, M. M. Giovanna, R. Alberto, C. Elena, G. Aldo, M. Lia, P. Piero, F. Clemente (Grosseto, Roma, Italy). Formoterol or tiotropium bromide do not influence isolated nocturnal hypoxemia in stable COPD. Eur Respir J 2005; 26: Suppl. 49, 1959
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Acute effect of formoterol, salmeterol, albuterol, oxitropium bromide and placebo on FEV1, inspiratory capacity and dyspnoea in COPD patients Source: Eur Respir J 2001; 18: Suppl. 33, 380s Year: 2001
Influence of higher than conventional doses of salbutamol or ipratropium bromide on bronchodilation induced by a regular treatment with tiotropium in patients suffering from stable COPD Source: Eur Respir J 2007; 30: Suppl. 51, 356s Year: 2007
Sleep architecture in COPD patients during salmeterol versus tiotropium bromide treatment Source: Eur Respir J 2006; 28: Suppl. 50, 199s Year: 2006
Salmeterol or ipratropium bromide/fenoterol in stable mild-to-moderate COPD Source: Eur Respir J 2001; 18: Suppl. 33, 426s Year: 2001
Sleep architecture in COPD patients during salmeterol versus ipratropium bromide treatment Source: Eur Respir J 2004; 24: Suppl. 48, 113s Year: 2004
Influence of tiotropium bromide and formoterol on bronchial hyperresponsiveness in COPD Source: Annual Congress 2012 - COPD treatment and varia Year: 2012
The efficacy of long-acting anticholinergic agent, tiotropium bromide on dynamic hyperinflation in COPD Source: Eur Respir J 2006; 28: Suppl. 50, 429s Year: 2006
Effectiveness of salmeterol versus ipratropium bromide on exertional dyspnoea in COPD Source: Eur Respir J 2001; 17: 1132-1137 Year: 2001
A comparison of bronchodilating response of salbutamol, ipratropium bromide and the combination of ipratropium-salbutamol in patients with stable chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 59s Year: 2001
A comparison of early bronchodilating responses of Salbutamol, Ipratropium bromide, and the combination of Ipratropium bromide-Salbutamol in stable patients with COPD or asthma Source: Eur Respir J 2002; 20: Suppl. 38, 246s Year: 2002
Effects of salbutamol and ipratropium bromide on arterial blood gases in patients with stable COPD Source: Eur Respir J 2001; 18: Suppl. 33, 253s Year: 2001
Long-acting inhaled anticholinergic therapy improves sleeping oxygen saturation in COPD Source: Eur Respir J 2004; 23: 825-831 Year: 2004
Effects of tiotropium bromide on bronchial obstruction and exercise tolerance in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 213s Year: 2006
Six months treatment with salmeterol or ipratropium bromide improves effort tolerance and reduces dyspnoea but does not have any effect on lung function in COPD Source: Eur Respir J 2002; 20: Suppl. 38, 108s Year: 2002
Comparison of nebulized ipratropium bromide with salbutamol versus salbutamol alone in acute asthma exacerbation in children Source: Eur Respir J 2004; 24: Suppl. 48, 167s Year: 2004
The combination therapy with inhaled tiotropium bromide and transdermal tulobuterol in COPD improves the peripheral airway function Source: Annual Congress 2010 - Bronchodilator treatment for asthma and COPD Year: 2010
Nebulized formoterol improves airway function in COPD subjects receiving maintenance tiotropium Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma Year: 2008
Comparative study of two years treatment with salmeterol alone and in combination with ipratropium bromide and beclometazone dipropionate in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2004; 24: Suppl. 48, 342s Year: 2004
Lung function response to budesonide and ipratropium bromide in COPD patients who continue smoking Source: Eur Respir J 2002; 20: Suppl. 38, 245s Year: 2002
Effects of procaterol or salmeterol added to maintenance tiotropium therapy on small airway functions in COPD patients Source: Annual Congress 2010 - COPD: management Year: 2010